Diclofenac Injection Dosing by Weight
For injectable diclofenac in adults, use 0.3 mg/kg for intravenous administration or approximately 2 mg/kg for intramuscular injection, with typical adult doses ranging from 18.75-75 mg depending on patient risk factors and body weight.
Adult Dosing Guidelines
Intravenous Administration
- Standard dose: 37.5 mg for non-high-risk patients
- High-risk patients (elderly ≥65 years, renal impairment, cardiovascular disease): 18.75 mg
- High body weight patients (≥95 kg): 50 mg
- Weight-based calculation: Approximately 0.3 mg/kg 1
The HPβCD-diclofenac formulation allows small-volume IV bolus administration and has demonstrated superior analgesic efficacy compared to ketorolac, with faster onset of analgesia and significantly lower opioid requirements 2.
Intramuscular Administration
- Weight-based dose: Approximately 2 mg/kg 3
- Typical adult dose: 75 mg IM provides effective analgesia
- Onset of antipyresis: Average 69 minutes with temperature reduction of 1.1°C after 1 hour 3
IM diclofenac provides more rapid analgesia than oral administration, achieving 50% pain reduction in 99.3% of patients within 30 minutes versus 86.7% with oral administration 4.
Pediatric Dosing (Ages 1-12 Years)
For children, use weight-based dosing as follows:
- Intravenous: 0.3 mg/kg 1
- Rectal suppository: 0.5 mg/kg 1
- Oral: 1 mg/kg 1
- Intramuscular: 0.5-1 mg/kg every 8 hours 5
These doses are derived from pharmacokinetic meta-analysis designed to achieve equivalent drug exposure (AUC) to a 50 mg adult dose 1.
Critical Dosing Considerations
Body Weight Impact
Higher body weight significantly affects diclofenac efficacy. Research demonstrates that:
- Fixed 100 mg doses show reduced effectiveness in heavier patients 6
- Diclofenac clearance increases with increasing body weight 7
- For optimal prophylactic effect, doses ≥1.0 mg/kg body weight are necessary 8
This is particularly important for procedures like ERCP where PEP prophylaxis is needed—doses below 1.0 mg/kg failed to prevent complications, while doses ≥1.0 mg/kg showed significant protective effects 8.
Age Considerations
- Elderly patients (≥65 years): Use reduced doses (18.75 mg IV) due to decreased volume of distribution, though clearance remains unchanged 7
- Diclofenac elimination half-life shows inverse relationship with age due to volume changes, not clearance alterations 7
Important Safety Caveats
Cardiovascular Risk
Both high-dose (≥150 mg/day) and low-dose (<150 mg/day) diclofenac carry similar cardiovascular risks, with approximately 50% increased rate of major adverse cardiovascular events (MACE) compared to non-users 9. The assumption that low-dose diclofenac is risk-neutral is not supported by evidence 9.
Contraindications and Cautions
- Avoid in patients with gastrointestinal disease, thrombocytopenia, or heart failure 9
- Use with gastric protection for prolonged therapy 10, 11
- Monitor for renal toxicity, particularly in at-risk patients 10, 11
- Intramuscular injections are painful and have no pharmacokinetic advantage over IV route 10
Route Selection
While IM diclofenac provides faster pain relief than oral administration (number needed to treat = 8 for 50% pain reduction at 30 minutes), the preparation time and injection discomfort may favor oral administration when clinical circumstances allow 4.
The key principle: weight-based dosing is essential for optimal efficacy, particularly in obese patients or when prophylactic effects are needed, but all routes and doses carry similar cardiovascular risks that must be weighed against analgesic benefits.